On February 13, 2023 Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, reported that it will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, March 16, 2023 at the New York Stock Exchange.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the event, Jim Davis, CEO and President, Sam Samad, Executive Vice President & CFO, and other senior executives will provide updated views of the U.S. laboratory market, the company’s business strategy, capital deployment priorities, and long-term outlook.
Advance registration is required. To register for the event, please go to: Quest Diagnostics Investor Day 2023 Registration.
A live webcast of the event will be broadcast on the Quest Diagnostics Investor Relations website.
An archived copy of the webcast will be available on the Quest Diagnostics Investor Relations website following the conclusion of the event